Mast cells can promote the development of multiple features of chronic asthma in mice

Journal of Clinical Investigation

Volumn 116, Issue 6, 2006, Pages 1633-1641

  Yu, Mang ^a   Tsai, Mindy ^a   Tam, See Ying ^a   Jones, Carol ^a   Zehnder, James ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; FC RECEPTOR; IMMUNOGLOBULIN G1 ANTIBODY; METHACHOLINE; MUCIN;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL HYPERPLASIA; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM CELL; GENE EXPRESSION; GOBLET CELL; INFLAMMATION; LYMPHOCYTE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WILD TYPE;

ANIMALS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERPLASIA; MAST CELLS; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, IGG; RESPIRATORY MUCOSA;

EID: 33745225217     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25702     Document Type: Article

References (61)

1. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
2. Busse, W.W., and Lemanske, R.F., Jr. 2001. Asthma. N. Engl. J. Med. 344:350-362.
3. Umetsu, D.T., McIntire, J.J., Akbari, O., Macaubas, C., and DeKruyff, R.H. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-720.
4. James, A. 2005. Airway remodeling in asthma. Curr. Opin. Pulm. Med. 11:1-6.
5. Davies, D.E., Wicks, J., Powell, R.M., Puddicombe, S.M., and Holgate, S.T. 2003. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 111:215-225; quiz 226.
6. Carroll, N.G., Mutavdzic, S., and James, A.L. 2002. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 57:677-682.
7. Rogers, D.F. 2004. Airway mucus hypersecretion in asthma: an undervalued pathology? Curr. Opin. Pharmacol. 4:241-250.
8. Marone, G., Triggiani, M., and de Paulis, A. 2005. Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol. 26:25-31.
9. Kitamura, Y. 1989. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7:59-76.
10. Metcalfe, D.D., Baram, D., and Mekori, Y.A. 1997. Mast cells. Physiol. Rev. 77:1033-1079.
11. Galli, S.J., et al. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23:749-786.
12. Brightling, C.E., et al. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699-1705.
13. Brightling, C.E., Bradding, P., Pavord, I.D., and Wardlaw, A.J. 2003. New insights into the role of the mast cell in asthma. Clin. Exp. Allergy. 33:550-556.
14. Kinet, J.P. 1999. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 17:931-972.
15. Kawakami, T., and Galli, S.J. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2:773-786.
16. Blank, U., and Rivera, J. 2004. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25:266-273.
17. Ravetch, J.V., and Kinet, J.P. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-492.
18. Latour, S., Bonnerot, C., Fridman, W.H., and Daeron, M. 1992. Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit. J. Immunol. 149:2155-2162.
19. Sylvestre, D.L., and Ravetch, J.V. 1996. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity. 5:387-390.
20. Miyajima, I., et al. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99:901-914.
21. Dombrowicz, D., et al. 1997. Absence of FcεRIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcεRI and FcγRIII for limiting amounts of FcRβ and γ chains. J. Clin. Invest. 99:915-925.
22. Finkelman, F.D., Rothenberg, M.E., Brandt, E.B., Morris, S.C., and Strait, R.T. 2005. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J. Allergy Clin. Immunol. 115:449-457; quiz 458.
23. Williams, C.M., and Galli, S.J. 2000. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105:847-859.
24. Boyce, J.A. 2003. The role of mast cells in asthma. Prostaglandins Leukot. Essent. Fatty Acids. 69:195-205.
25. Galli, S.J. 1997. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J. Exp. Med. 186:343-347.
26. Humbles, A.A., et al. 2004. A critical role for eosinophils in allergic airways remodeling. Science. 305:1776-1779.
27. Lee, J.J., et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 305:1773-1776.
28. Miyahara, N., et al. 2004. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat. Med. 10:865-869.
29. Djukanovic, R., et al. 2004. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am. J. Respir. Crit. Care Med. 170:583-593.
30. Holgate, S., et al. 2005. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol. 115:459-465.
31. Taube, C., Dakhama, A., and Gelfand, E.W. 2004. Insights into the pathogenesis of asthma utilizing murine models. Int. Arch. Allergy Immunol. 135:173-186.
32. Kobayashi, T., et al. 2000. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 164:3855-3861.
33. Williams, C.M., and Galli, S.J. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192:455-462.
34. Taube, C., et al. 2004. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172:6398-6406.
35. Takeda, K., et al. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186:449-454.
36. Henderson, W.R., Jr., et al. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165:108-116.
37. Ikeda, R.K., et al. 2003. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol. 171:4860-4867.
38. Kumar, R.K., Herbert, C., and Foster, P.S. 2004. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin. Exp. Allergy. 34:567-575.
39. Marshall, J.S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4:787-799.
40. Galli, S.J., Nakae, S., and Tsai, M. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6:135-142.
41. Ravetch, J.V. 1994. Fc receptors: rubor redux. Cell. 78:553-560.
42. Carlow, D.A., Marth, J., Clark-Lewis, I., and Teh, H.S. 1995. Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif. J. Immunol. 154:1724-1734.
43. Kirkham, S., Sheehan, J.K., Knight, D., Richardson, P.S., and Thornton, D.J. 2002. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem. J. 361:537-546.
44. Asai, K., et al. 2001. Regulation of mast cell survival by IgE. Immunity. 14:791-800.
45. Kalesnikoff, J., et al. 2001. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 14:801-811.
46. Kitaura, J., et al. 2003. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the Fc epsilon RI. Proc. Natl. Acad. Sci. U. S. A. 100:12911-12916.
47. Yamasaki, S., Ishikawa, E., Kohno, M., and Saito, T. 2004. The quantity and duration of FcR gamma signals determine mast cell degranulation and survival. Blood. 103:3093-3101.
48. Kohno, M., Yamasaki, S., Tybulewicz, V.L., and Saito, T. 2005. Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen. Blood. 105:2059-2065.
49. W-sh sash mice. Clin. Exp. Allergy. 35:82-88.
50. -sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167:835-848.
51. Zhu, D., et al. 2005. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat. Med. 11:446-449.
52. Singer, M., et al. 2004. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat. Med. 10:193-196.
53. Humbles, A.A., et al. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature. 406:998-1001.
54. Krug, N., Tschernig, T., Erpenbeck, V.J., Hohlfeld, J.M., and Kohl, J. 2001. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit. Care Med. 164:1841-1843.
55. Nockher, W.A., and Renz, H. 2006. Neurotrophins and asthma: novel insight into neuroimmune interaction. J. Allergy Clin. Immunol. 117:67-71.
56. Stimler-Gerard, N.P., and Galli, S.J. 1987. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction. J. Immunol. 138:1908-1913.
57. Takai, T., Li, M., Sylvestre, D., Clynes, R., and Ravetch, J.V. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529.
58. Eisenbarth, S.C., et al. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.
59. Martin, T.R., Gerard, N.P., Galli, S.J., and Drazen, J.M. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318-2323.
60. Spergel, J.M., et al. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101:1614-1622.
61. Savani, R.C., et al. 2000. Bleomycin-induced pulmonary injury in mice deficient in SPARC. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L743-L750.